The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and that is still a a very important tool in in oncology today — a large fraction of tumors are sequenced and that's what allows people to get you know — access to many types of drugs right — um — you know many of the targeted — therapies for lung cancer melanoma or you hear about things like you know micro satellite instability or high mutational burden that all comes from you know tumor sequencing
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.